SHARON BROWN: Open Payments
NPI 1720299449 · SAINT JOHNS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$991 in 28 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $25 · 2025 $991
Food & beverage: $991
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 9 | $222 |
| ABBVIE INC. | 6 | $149 |
| Lilly USA, LLC | 3 | $130 |
| Novo Nordisk Inc | 1 | $125 |
| Edwards Lifesciences Corporation | 1 | $91 |
| Dexcom, Inc. | 1 | $90 |
| Axsome Therapeutics, Inc. | 1 | $76 |
| Merck Sharp & Dohme LLC | 2 | $38 |
| Exact Sciences Corporation | 2 | $34 |
| Insulet Corporation | 1 | $20 |
Products named: EVENITY, Ozempic, QULIPTA, ZEPBOUND, SAPIEN 3 Ultra RESILIA, Dexcom G6 Transmitter, Auvelity, OTEZLA.
Industry payments across FL — which companies pay providers there.
